Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors.
Alberto BorghettiArturo CicculloF LombardiGianmaria BaldinSimone BelmontiM ProsperiF IncardonaE HegerV BorghiA SönnerborgM ZazziA De LucaS Di GiambenedettoPublished in: HIV medicine (2020)
NRTI backbone TDRMs increased the risk of VF with raltegravir-based but not dolutegravir-based regimens.